The matrix (M) protein of vesicular stomatitis virus (VSV) plays significant roles in the replication of VSV through its involvement in the assembly of virus particles as well as by facilitating the evasion of innate host cell defense mechanisms. The presence of methionine at position 51 (M51) of the matrix (M) protein of the VSV Indiana serotype (VSV Ind ) has been proven to be crucial for cell rounding and inhibition of host cell gene expression. The M protein of VSV Ind with the substitution of M51 with arginine (R:M51R) results in the loss of inhibitory effects on host cell gene expression. The VSV Ind expressing the M(M51R) protein became the attractive oncolytic virus which is safer and more tumor-specific because the normal cells can clear the mutant VSV Ind easily but tumor cells are susceptible to the virus because a variety of tumor cells lack innate antiviral activities. We have studied the role of the methionines at positions 48 and 51 of the M protein of the New Jersey serotype of VSV (VSV NJ ) in the induction of cytopathic effects (CPE) and host cell gene expression. We have generated human embryonic kidney 293 cell lines inducibly expressing M proteins with M to R mutations at positions 48 and 51, either separately or together as a double mutant, and examined expression of heat shock protein 70 (HSP70) as an indicator of host cell gene expression. We have also generated recombinant VSV NJ encoding the mutant M proteins M(M48R) or M(M48R + M51R) for the first time and tested for the expression of HSP70 in infected cells. Our results demonstrated that the M51 of VSV NJ M proteins has a major role in cell rounding and in suppressing the host cell gene expression either when the M protein was expressed alone in inducible cell lines or when expressed together with other VSV proteins by the recombinant VSV NJ . Amino acid residue M48 may also have some role in cell rounding and in the inhibitory effects of VSV NJ M, which was demonstrated by the fact that the cell line expressing the double substitution mutant M(M48R + M51R) exhibited the least cytopathic effects and the least inhibitory effect on host cell gene expression.
Introduction
Vesicular stomatitis virus (VSV), the prototype virus of the Rhabdoviridae, induces typical cell rounding that leads to the lysis of infected eukaryotic cells (Simon et al., 1990) . Although the 48 nucleotide-long, plus-sense leader RNA or other components of VSV have been implicated as the cause of the CPE by VSV (Grinnell and Wagner, 1983; Kopecky et al., 2001) , the well documented cause of CPE has been the expression of the matrix (M) protein during VSV replication. The direct and indirect mechanisms by which the M protein induces CPE are disorganization of cytoskeletal elements such as actin or tubulin by association with them (Blondel et al., 1990; Melki et al., 1994) and general inhibition of host cell gene expression (Black and Lyles, 1992) , which can result in the systemic breakdown of the cell by apoptosis (Kopecky and Lyles, 2003) .
VSV has two major serotypes: Indiana (VSV Ind ) and New Jersey (VSV NJ ). Matrix proteins of both VSV Ind and VSV NJ have 229 amino acids with about 59%-62% amino acid sequence identity (Gill and Banerjee, 1986) . In addition to the first methionine, 2 other methionines are conserved at positions 33 (M31) and 51 (M51) in both M proteins of VSV Ind and VSV NJ within the NH 2 -terminal 51 amino acids. It has been Virology 357 (2007) 41 -53 www.elsevier.com/locate/yviro suggested that these two methionines may play a role in producing truncated M proteins via internal translation initiation and in the induction of cell rounding by VSV Ind (Jayakar and Whitt, 2002 It has been demonstrated that the VSV M protein inhibits the expression of host cell proteins by inhibiting cellular transcription (Ahmed and Lyles, 1998; Black and Lyles, 1992) and by blocking the nuclear export of a broad range of cellular RNAs including spliced mRNAs (Her et al., 1997) . The amino acid residue in the M protein of VSV Ind , which is critical for the inhibition of host cell gene expression, is the methionine at position 51 (M51). The importance of the M51 for the inhibition of host cell gene expression was first indicated by the conditional temperature-sensitive M mutant of VSV Ind , tsO82 (Coulon et al., 1990) . It has been demonstrated that M51 of VSV Ind M protein has a major role in disrupting nucleocytoplasmic transport of mRNAs by binding directly to components of the nuclear pore complex such as Nup98, one of the nucleoporins (Enninga et al., 2002; Petersen et al., 2001 Petersen et al., , 2000 von Kobbe et al., 2000) , and/or by interrupting the interaction between Nup98 and Rae1/mrnp41 (Faria et al., 2005) , a shuttling mRNA export factor that is bound by M protein as well. Replacement of M51 with either arginine (R), alanine (A), leucine (L) or aspartic acid (D) reduced the inhibitory effect of M protein on the nuclear export of cellular RNAs (Petersen et al., 2000; von Kobbe et al., 2000) .
VSV became an attractive oncolytic agent for cancer therapy because of its wide host cell range, rapid replication and mild pathogenicity in humans. Because VSV M proteins having the M51R mutation lack the inhibitory effect on host cell gene expression, VSV expressing the mutant M protein loses the means to counteract the antiviral activity of host cells such as interferon (IFN) induction (Ahmed et al., 2003) and overall inhibition of translation mediated by PKR activation. The cancer cells are impaired with responsiveness to both type I (IFN-α, -β) and type II IFN (IFN-γ), which is one of the important innate host defense mechanisms against viral infection (Balachandran and Barber, 2004) . In addition, transformed cells have an increased level of eIF2Bε, a catalytic subunit of eIF2B and a guanine nucleotide exchange factor (Balachandran and Barber, 2004) . The subunits of eIF2B are involved in converting the inactive form of eIF2·GDP to the active eIF2·GTP, which is required to form a eukaryotic translation initiation complex. The activity of eIF2B is normally reduced in the non-tumor cells by the activation of IFN-induced RNA-dependent protein kinase PKR and eIF2α phosphorylation. The lack of innate defense mechanisms in transformed cells makes them more susceptible to the VSV infection than primary cells (Balachandran and Barber, 2004; Stojdl et al., 2000; Stojdl et al., 2003) . VSV expressing the M protein with M51R mutation [M(M51R)] can be readily cleared from normal cells by an antiviral defense mechanism, whereas the transformed cells which lack the antiviral activity are equally well infected and lysed by both the mutant and wild type VSV. These characteristics of the transformed cells and VSV expressing M (M51R) have resulted in the mutant VSV being considered as a safer and tumor-cell-specific oncolytic agent.
In this study, we examined the effects of the M33, M48 and M51 of the VSV NJ M protein on host cell gene expression and cell death. We generated tetracycline-inducible cell lines expressing VSV NJ M mutants which contained individual substitutions of arginines at positions M33, M48 and M51 and a double substitution of both positions M48 and M51. Recombinant VSV NJ was recovered from cDNA for the first time, and the activity of mutant M proteins with the M48R or M48R + M51R mutations encoded within the recombinant virus was also examined. Our results demonstrated that M51 of VSV NJ M protein has a major role in the induction of cell rounding and inhibition of host cell gene expression either when the M protein was expressed alone or when expressed together with other VSV proteins. Amino acid residue M48 may be partially responsible for the cell rounding and the inhibitory effect on gene expression, as demonstrated by the least cytopathic effects and the least inhibitory effects on the host cell gene expression in the cell line expressing the double mutant M(M48R + M51R) of VSV NJ .
Results

Transient expression of wild type and mutant matrix proteins of VSV NJ
Matrix proteins of both VSV Ind and VSV NJ consist of 229 amino acids with about 60% amino acid sequence identity. The NH 2 -terminal regions of M proteins from both serotypes are highly basic, and the hydrophobic region and the PPPY motif that are involved in virus budding (Jayakar et al., 2000) are also conserved. Both serotypes of VSV possess methionines at positions 33 and 51 within the NH 2 -terminal 51 amino acids of the M protein. The M33 and M51 of the VSV Ind M protein have been shown to play important roles in cell rounding (Jayakar and Whitt, 2002) and in inhibiting host cell gene expression (Ahmed et al., 2003; von Kobbe et al., 2000) . There is one additional methionine at position 48 in the VSV NJ M protein (Fig. 1) . In order to examine the importance of the methionines at positions 33, 48 and 51 in the CPE and inhibitory effects on the host cell gene expression by the VSV NJ M proteins, individual or combined methionine to arginine mutations were introduced (Fig. 1) .
It has been demonstrated previously that the expression of VSV Ind M proteins from eukaryotic expression vector is selflimiting (Black and Lyles, 1992; Blondel et al., 1990) as it acts to inhibit its own transcription. Therefore, we cloned the wild type and mutant M gene cDNAs into two separate plasmid expression vectors in which the transcription is driven by the bacteriophage T7 transcriptional promoter (pBKS-M) or by the eukaryotic CMV promoter (pcDNA5-M). T7 promoter mediated expression of M protein was examined by transfecting recombinant vaccinia virus vTF7-3 infected BHK 21 cells with cDNA plasmids of the wild type and mutant M genes. CMV promoter mediated expression of M protein was examined by transfecting BHK 21 cells with pcDNA5-M clones without vTF7-3 infection. The transfected cells were labeled with 35 S-met for 3 h at 20 h post transfection, and the M protein was immunoprecipitated using polyclonal antiserum against VSV NJ whole virus. High levels of all mutant and wild type M proteins [M(wt)] were expressed by the T7 RNA polymerase that was provided by the recombinant vaccinia virus in the cytoplasm ( Fig. 2A) . Compared to the T7 promoter driven expression of M proteins, CMV promoter driven expression of M protein was only detectable in cells transfected with pcDNA5-M(M51R) and pcDNA5-M(M48R + M51R) (Fig. 2B) . The results suggest that methionine at 51 of VSV NJ M protein has a critical role in inhibiting gene expression by the host cellular RNA polymerase as has been demonstrated by the M51 substitution of VSV Ind M protein. and budding of VSV Ind (Black et al., 1993; Jayakar and Whitt, 2002) . In order to study the effects of M to R changes at positions 33, 48 and 51 in the VSV NJ M protein on the assembly and budding of VSV NJ , we recovered VSV NJ panhandle DI particles from the cDNA using the VSV reverse genetics system (Kim and Kang, 2005) . Since the panhandle type VSV DI particle contains all the necessary cis-acting sequences at the 3′ and 5′ termini of its genome for replication and budding, the recovery of the DI particles using the wild type and mutant VSV NJ M proteins was ideal for this study. VSV NJ DI particles containing bacteriophage λ sequences NJ DI (227-188) (Kim and Kang, 2005) were recovered from cDNA using either the wild type or mutant VSV NJ M proteins as described in the Materials and methods. The recovered DI particles were amplified once by coinfecting BHK 21 cells with an MOI of 3 of the standard VSV NJ in a 6 well culture plate. At 15 h postinfection, 2 ml of culture fluid containing amplified DI particles and VSV NJ standard virus was collected. Fresh BHK 21 cells in a 6 well culture plate were infected with 300 μl of the harvested culture media. At 5 h postinfection, the cells were lysed and DI particle RNA was isolated as described previously (Kim and Kang, 2005) . The presence of bacteriophage λ sequences in the extracted DI particle RNA was determined by Northern blot analysis using a λ-specific riboprobe. Correct sizes of NJ DI (227-188) genomic RNA were detected in all of the cells infected with recovered DI particles (Fig. 3 ). This result demonstrates that the respective M to R mutations at positions 33, 48 and 51 do not affect the assembly and budding function of the VSV NJ M protein.
VSV NJ M protein with M48R + M51R double mutation is the least cytopathic
Examination of the effects of the M protein on cell rounding and host cellular gene expression by transfection of DNA plasmid is not suitable because all cells are not transfected equally and the M protein can inhibit its own expression from the plasmid, resulting in overall insufficient effects on cells. In order to circumvent the self-limiting expression of M proteins from the plasmid DNA, other researchers have used mRNAs of the M protein gene that were prepared by in vitro transcription to transfect the cells (Ahmed and Lyles, 1998; Lyles and McKenzie, 1997) . But the results from the transfection of mRNA can be variable depending on the transfection efficiency. In order to have all the cells in the culture dish express M protein and because a very small quantity of M protein can induce cytopathic effects (Black and Lyles, 1992) , we generated tetracycline-inducible human 293 cell lines which express wild type M protein: M(wt), two single mutants: M(M48R) and M (M51R), and one double mutant: M(M48R + M51R). The results shown in Fig. 2B suggest that M(wt) and M(M33R) have the same effect on host cell gene expression. Therefore, we were interested to know the outcome of M48 and M51 mutations to arginine. In order to examine the role of methionines at positions 48 and 51, separately and together, each inducible cell line was treated with 1 μg/ml of tetracycline for 24 h to induce M protein expression. The cell lysates were prepared to detect the expression of M proteins by Western blot analysis using polyclonal antiserum against whole VSV NJ . Most of the cells expressing M(wt) were rounded up and detached ( Fig. 4A-1 ), whereas cells expressing M(M48R) showed less cytopathic effect than the cells expressing M(wt) ( Fig . This result is consistent with the previous observation that a minute quantity of M protein can be detrimental to host cells (Black and Lyles, 1992) . Our result demonstrates that M51 in the VSV NJ M protein plays a major role in the inhibition of cell rounding in 293 cells whereas M48 may have little effect on the cell rounding.
It has previously been demonstrated that the M(wt) protein of VSV Ind alone causes apoptosis in BHK cells and HeLa cells (Kopecky et al., 2001 ). The induction of apoptosis was closely related to the presence of M51 in the M protein and inhibition of host cellular gene expression by the M protein, which was demonstrated using the M51R mutant. Therefore, we examined the effects on apoptosis of M to R mutations in the VSV NJ M protein at positions 48 and 51, both individually and together. Approximately 5 × 10 6 cells in a 60 mm culture dish were Fig. 3 . Substitutions of methionines to arginines at positions 33, 48 and 51 in the VSV NJ M protein do not affect its role in virus budding. VSV NJ panhandle type DI particle NJ DI (227-188) was recovered by cotransfecting pTV-HDI(227-188), pBKS-N NJ , pBKS-P NJ , pBKS-G NJ , pBKS-L NJ and pBKS-M NJ (wt or M to R mutants) as described previously (Kim and Kang, 2005) . The presence of the DI particle genomic RNA was detected by Northern blot analysis using the DI particle genome specific riboprobe.
treated with 1 μg/ml of tetracycline for 24 h to induce M protein expression and cell lysates were used to isolate low molecular weight DNAs for the DNA fragmentation assay (Fig. 5A ) and to determine the caspase-3 activity by colorimetric assay (Fig. 5B ). Both apoptotic assays demonstrated that M(wt) induces the strongest apoptotic effect ( VSV NJ M protein with M48R + M51R mutation loses its inhibitory effect on host cellular gene expression
Human 293 cells express heat shock protein 70 (HSP70) constitutively with or without heat treatment (Theodorakis and Morimoto, 1987) as shown in Fig. 6 , lanes 10 and 11. Therefore, we chose the expression of HSP70 as an indicator to test the inhibitory effect of wild type and mutant M proteins of VSV NJ on host cell gene expression.
In order to examine the effects of the mutations of the M protein on the expression of HSP70, the expression of M protein was induced first by treating the cell lines with 1 μg/ ml of tetracycline followed by heat shock at 44°C for 10 min to induce the HSP70. The expression of HSP70 was determined by labeling the cell with 30 μCi/ml of 35 S-met for 2 h at 3 h after heat shock and immunoprecipitating the HSP70 using a monoclonal antibody against human HSP70. The expression of M proteins in the same cell lines was examined by labeling the cells with 35 S-met at 20 h after the induction of the M protein. The M protein was immunoprecipitated using the antibody against VSV NJ . There was a slight increase in the expression of HSP70 in the parental human 293 cells after heat shock (Fig. 6, lanes 10 and 11) . In the absence of M protein expression, all cell lines expressed levels of HSP70 similar to those of the control parental 293 cells (Fig. 6, lanes 2, 4, 6 , 8, 10 and 11). The cell lines expressing M(M51R) and M(M48R + M51R) showed similar levels of HSP70 expression to those which were not treated with tetracycline (Fig. 6, lanes 7 and 9) . However, the expression of HSP70 was decreased significantly in cell lines expressing M(wt) and M(M48R) (Fig. 6, lanes 3 and 5) . Next we examined whether or not the M51R mutation continues to reduce cytopathogenicity and inhibition of host cell gene expression in the presence of other VSV NJ proteins. In order to address this question, we generated full-length cDNA clones of VSV NJ and recovered the viruses containing M genes which encode M(wt), M(M48R) and M(M48R + M51R) separately. The cloning of the full-length genome (Fig. 7) and recovery of VSV NJ from the cDNA clone were carried out by reverse genetics as described in Materials and methods. The growth rates of recombinant VSV NJ , rWT, rM(M48R) and rM (M48R + M51R) were determined by infecting BHK 21 cells and human 293 cells at an MOI of 3. Both wild type and mutant viruses showed similar patterns of replication in both cell lines, although the viruses replicated slower in the human 293 cells compared to the BHK 21 cells (Fig. 8) . The VSV NJ expressing M (M48R) or M(M48R + M51R) replicated slower than the viruses expressing M(wt) during the first 6 h after infection (Fig. 8) . The recombinant viruses reached a peak titer at 8 h postinfection when the viruses were grown in human 293 cells and maintained similar level of replication until 10 h postinfection (Fig. 8B) . In order to examine the effect of VSV NJ expressing M (M48R) or M(M48R + M51R) on the host cellular protein synthesis, human 293 cells were infected with the recombinant VSV NJ at an MOI of 6 and the infected cells were labeled with 30 μCi/ml of 35 S-met for 1 h at 8 h postinfection. Overall cellular protein synthesis and VSV NJ protein synthesis were examined by SDS-PAGE using equal amounts of cell lysates (15 μg), which was demonstrated by staining the gel with Coomassie blue (Fig. 9A) and by Western blot analysis of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the same samples (Fig. 9B, lower panel) . The 35 S-met labeled proteins were visualized by autoradiography (Fig. 9B, upper  panel) . The remaining cell lysates were divided into two aliquots for immunoprecipitation using the antibody against HSP70 and the antibody against VSV NJ . The substitution of M with R at positions 48 and 51 in the M protein made migration of the M protein slightly faster than that of the wild type (Fig. 2) , and the pattern was also shown in the cells infected with the recombinant VSV NJ expressing M(M48R) and (M48R + M51R) (Figs. 9B and C, upper panel, lanes 3 and 4) , demonstrating that the recombinant viruses expressed mutant M proteins. The overall protein synthesis was maintained at about 60% and 25% of uninfected cells in the cells infected with rM(M48R + M51R) or rM(M48R) compared to the 2% to 12% protein synthesis in cells infected with wild type virus (Fig. 9B) . The results demonstrate that M(M48R + M51R) lost its inhibitory activity on the host cellular protein synthesis significantly and substitution of M48R has slight effects on the host cell gene expression in cells infected with VSV NJ . The overall VSV protein synthesis was also increased in cells infected with rM (M48R + M51R) compared to the cells infected with wild type or with rM(M48R) (Fig. 9B, lane 4) , which demonstrates that decreased inhibition of host cellular protein synthesis correlates with increased VSV protein synthesis. The expression of HSP70, an indicator for host cell gene expression, decreased to an undetectable or significantly low level in cells infected with wild type VSV NJ and VSV NJ M(M48R) respectively (Fig. 9C,   Fig. 8 . Single cycle growth curve of wild type and methionine to arginine substitution mutant viruses of VSV NJ . BHK 21 cells (A) and human 293 cells (B) were infected at an MOI of 3 of the viruses. After 1 h of adsorption, the infected cells were washed twice and 500 μl of culture media was taken immediately from the culture dish as a sample at 0 h. The same volumes (500 μl) of culture media were taken and fresh media were added every 2 h until 10 h postinfection. Viral titer was determined by standard plaque assay. The viral titer at each time point represents the average of triplicate experiments. lower panel, lanes 1, 2 and 3). The cells infected with VSV NJ rM (M48R + 51R) expressed levels of HSP70 equivalent to about 60% of uninfected cells (Fig. 9C, lanes 4 and 5) . The results demonstrate that the M51 in the VSV NJ M protein, as with the VSV Ind M protein, plays a major role in the blocking of host cell gene expression. The results also suggest that M48 may have a slight effect in blocking host cell gene expression.
Discussion
VSV, a single stranded negative sense RNA virus, has become a useful tool for the treatment of cancer (Balachandran et al., 2001; Ebert et al., 2005; Obuchi et al., 2003; Stojdl et al., 2003) and for the expression of antigens in host animals to induce immune responses (Egan et al., 2004; McKenna et al., 2003; Rose et al., 2001) . As an oncolytic viral agent, VSV which encodes the mutant M protein that has lost its inhibitory effect on host cell gene expression is gaining attention as an alternative virus to wild type VSV because of its improved safety (Ahmed et al., 2004; Ebert et al., 2004; Stojdl et al., 2003) . All of the works on VSV as an oncolytic virus and as a foreign gene delivery vector have been performed using VSV Ind . Another serotype of VSV, VSV NJ , which is not neutralized by antibodies against VSV Ind has not yet been generated as a recombinant virus from cDNA. Here we have investigated the effects of M to R mutations at positions 33, 48 and 51 of VSV NJ M protein on CPE and host cell gene expression using cell lines which express M protein, as well as recombinant VSV NJ which expresses the wild type M protein or the mutant M proteins. Double substitutions at M48 and M51 with R in the VSV NJ M protein, both in cells expressing the protein alone or from the recombinant VSV NJ , showed a drastic reduction of inhibitory effects on host cell gene expression.
The NH 2 -terminal region of the VSV M protein contains important amino acid residues required to support the replication of VSV during virus particle assembly and escape from innate cellular antiviral activity. The PPPY motif from positions 24 to 27 is critical for VSV budding from the cell surface (Craven et al., 1999; Jayakar et al., 2000) . The translation codons for M33 and M51 in the VSV Ind M protein have been suggested as being used for the synthesis of two additional NH 2 -terminally truncated M proteins, which have been suggested to be responsible for cell rounding (Jayakar and Whitt, 2002) . It has been demonstrated that the M51 of the VSV Ind M protein is involved in its association with nucleoporins, which leads to the blocking of nucleocytoplasmic transport of cellular RNAs and in inhibiting overall cellular gene expression (Coulon et al., 1990; Petersen et al., 2000; von Kobbe et al., 2000) . The VSV NJ M protein has three methionines at the NH 2 -terminal region, M33, M48 and M51. M33 and M51 are conserved in both VSV Ind M and VSV NJ M proteins. When the VSV M protein is expressed from a plasmid containing a eukaryotic promoter, a very small quantity of M protein can inhibit its own synthesis from the plasmid (Black and Lyles, 1992; Blondel et al., 1990) , which can reflect the effect of inhibition of host cellular gene expression by the M protein. When we expressed the mutant VSV NJ M proteins from the eukaryotic plasmid vector, or in tetracycline-inducible cell lines, VSV NJ M proteins containing the M51R mutation, M (M51R) and M(M48R + M51R), were detected in good quantity, however, little to no M protein was detected in M(M48R) or M (wt) expressing cell cells (Figs. 2B and 4B ). This indicates that it is mostly the M51 of VSV NJ M protein which is involved in the inhibition of host cell gene expression as in VSV Ind . M48 is conserved in M proteins of both VSV NJ (Haz) and VSV NJ (Ogd) strains. Although the single mutation at M48R does not affect the inhibitory effect of the VSV NJ M protein significantly, the substitution of both M48 and M51 together as in the M(M48R + M51R) caused an increased reduction of its inhibitory effects on host cell gene expression relative to that of the single mutation M51R (Figs. 4B and 6 ). This result demonstrates that both M48 and M51 may be involved in binding nuclear pore complexes such as Nup 98 (von Kobbe et al., 2000) . The apoptotic cell death induced by the VSV Ind M protein is closely related to the inhibition of host cell gene expression by the M protein (Kopecky and Lyles, 2003; Kopecky et al., 2001) . Therefore, the more the M protein loses its inhibitory effects on the host cell gene expression, the less it is capable of inducing CPE and apoptosis, which was demonstrated by the M(M48R + M51R) of VSV NJ in our experiments (Figs. 4A and 5) . Although the M protein with M48R mutation inhibits the production of HSP70 expression when it is expressed alone in the tetracyclineinducible cell line (Fig. 6) , the cellular caspase-3 activity and subsequent DNA fragmentation was reduced significantly with the M48R mutation compared to the wild type M protein (Fig.  5) . In addition, the M48R and M51R double mutation resulted in a much higher level of M protein synthesis compared to the M51R single mutation in cell lines expressing the M proteins (Fig. 4B) . These results indicate that not only the M51R mutation but also the M48R mutation is required for optimal reduction of cytotoxicity in infected cells. Thus, it is desirable to change methionines at both positions M48 and M51 to arginines to generate VSV NJ as a gene expression vector or an oncolytic virus.
Although VSV is a rapidly replicating virus which can infect tumor cells quickly, eventually humoral and cellular immune responses against VSV will be elicited in the animal host (Kalinke et al., 1996; Puddington et al., 1986; Yewdell et al., 1986 ). An animal infected with VSV develops immune responses within 1 or 2 weeks (Kalinke et al., 1996) and starts to neutralize the VSV, which makes the cancer treatment or foreign gene delivery via VSV incomplete. This hinders the efficacy of additional treatments for cancer therapy or boost immunizations for vaccination with the same vector. The two different serotypes of VSV, VSV Ind and VSV NJ , show 50% amino acid identity in the glycoprotein (Gallione and Rose, 1983) . Antibodies raised against one serotype of VSV do not neutralize the other serotype of VSV (Cartwright and Brown, 1972) . Therefore, others have used VSV Ind as a vaccine vector in which the glycoprotein was replaced with that of VSV NJ to minimize the problems arising from this immune response against the viral vectors (Rose et al., 2001 (Rose et al., , 2000 . Although the VSV Ind with G protein replaced with VSV NJ serotype is useful in evading the humoral immune response, it will not prevent the cellular immune response which can be triggered by nucleocapsid or matrix proteins. The cellular immune responses against VSV proteins other than the G protein may result in incomplete immune responses against the antigen of interest or failure to complete oncolytic treatment. Therefore, the generation of additional recombinant VSV from another serotype can increase the efficacy of using VSV as an oncolytic virus and as a live viral vaccine vector. Our data show that VSV NJ encoding M (M48R + M51R) loses its inhibitory effect on host cell gene expression (Fig. 9) , thereby making it a good candidate for more efficient cancer therapies. In addition, recombinant VSV NJ is an effective viral vector for the expression of foreign genes, which can be used to minimize problems associated with preexisting immune responses against VSV itself.
Materials and methods
Cells and viruses
BHK 21 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS). Flp-In T-REx 293 cells (Invitrogen) were cultured in DMEM containing 10% FBS, 100 μg/ml zeocin and 15 μg/ml blasticidine. Tetracycline-inducible Flp-In T-REx 293 cells expressing VSV NJ wild type or VSV NJ M protein mutant were cultured in DMEM containing 10% FBS, 15 μg/ml blasticidine and 400 μg/ml hygromycin B. The BHK cell line expressing T7 RNA polymerase, BSR T7/5 (Buchholz et al., 1999) , was grown in DMEM containing 5% FBS and 500 μg/ml geneticin. Recombinant VSV NJ was generated from the VSV NJ (Haz) strain (Dr. S. Emerson, NIH, Bethesda, MD). The recombinant and wild type VSV NJ were purified 3 times by plaque picking and amplified in BHK 21 cells. Recombinant vaccinia virus expressing T7 DNA-dependent RNA polymerase, vTF7-3 (Fuerst et al., 1986) , was prepared in TK − 143 cells as described previously (Mackett et al., 1985) .
Plasmids
Construction of cDNA clones of VSV NJ (Haz) genes in the pBluescript II KS vector (pBKS; Stratagen), pBKS-N NJ , pBKS-P NJ , pBKS-M NJ , pBKS-G NJ and pBKS-L N J has been described previously (Kim et al., 2002; Kim and Kang, 2005) . Plasmids encoding VSV NJ M protein mutants under the control of the T7 promoter, pBKS-M NJ (M33R), pBKS-M NJ (M48R), pBKS-M NJ (M51R) and pBKS-M NJ (M48R + M51R), were generated in pBKS-M NJ by megaprimer PCR-based site-directed mutagenesis (Sarkar and Sommer, 1990) . The schematics and primers for the construction of mutant pBKS-M NJ are described in supplement 1. Plasmids expressing VSV NJ wild type and mutant M under the control of the CMV promoter were constructed by inserting DNA fragments of M genes from the pBKS-M NJ wild type and the mutants into the NotI site of pcDNA5/FRT/TO (Invitrogen). The resulting plasmids were designated as pcDNA5-M NJ (wt), pcDNA5-M NJ (M33R), pcDNA5-M NJ (M48R), pcDNA5-M NJ (M51R) and pcDNA5-M NJ (M48R + M51R).
VSV NJ nucleocapsid (N), phosphoprotein (P) and Large protein (L) gene clones in the pBKS vector containing internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV) 5′-untranslated region (pBKS-IRES/N NJ , pBKS-IRES/P NJ and pBKS-IRES/L NJ ) were generated by inserting IRES sequences to the upstream of each gene. First, the IRES sequence was amplified from the pTM1 vector (Elroy-Stein et al., 1989) by polymerase chain reaction (PCR) using the primers IRES5′ and IRES3′ and then cloned into the pBKS vector using a NotI site, resulting in the pBKS-IRES. After confirmation of the correct IRES sequence in the pBKS-IRES, the IRES sequence was cut with NotI and inserted upstream of the VSV NJ gene cDNAs in the pBKS-N NJ , pBKS-P NJ and pBKS-L NJ , with the interrupting sequences remaining between the IRES and the beginning of each gene. In order to use the 11th AUG sequence in the IRES as a start codon without interruption of any other sequence between the IRES and each gene sequence, the DNA fragments containing continuous sequences from the end of the IRES to the beginning of the respective gene were amplified by megaprimer PCR (Sarkar and Sommer, 1990) . The regions containing extra sequences were replaced by the megaprimer PCR products. Briefly, the megaprimers containing the 3′ 132 nucleotides (nts) of the IRES and beginning the N NJ , P NJ and L NJ gene sequences were amplified by the first PCR using a primer IRES-375 and pairing primers IRES-HN, IRES-HP and IRES-HL for respective genes. The first PCR products were purified and used with primers HN BglII, HP MfeI and HL PflfI for the second PCR to amplify the continuous sequences encompassing the 3′ IRES 132 nts and various lengths of N, P and L gene 5′ sequences.
The full-length cDNA clone of the VSV NJ genome was constructed by assembling four RT-PCR products and three PCR products into the transcription vector pTV (Kim et al., 2002; Pattnaik et al., 1992) . The 7 PCR products were put together sequentially, and finally the NdeI digest from pBKS-L NJ was cloned into the previously assembled cDNA clone (Fig.  7) . The full-length cDNA clone of VSV NJ was named as pTV-VSV NJ (rwt). The full-length antigenomic RNA of VSV NJ is encoded from the pTV-VSV NJ (rwt) by the T7 RNA polymerase. The restriction enzyme sites shown in Fig. 7 are included in each fragment and were used to assemble the full-length clone. Subclones of A, B, F and G fragments (Fig. 7) were generated in the pBKS vector by RT-PCR using the genomic RNA isolated from the purified VSV NJ (Haz). The fragments of C, D and E (Fig. 7) were generated by PCR using the cDNA clone of each gene as a template and were cloned into pBKS. The primers (numbers 1 to 15) used for the RT-PCR and PCR are described in Fig. 7 . All subclones were sequenced and compared with the sequences of VSV NJ gene clones which were previously used successfully for the recovery of DI particles (Kim et al., 2002) . Segment A was generated by the megaprimer PCR method using three separate primers. A small, double-stranded DNA fragment containing the T7 transcriptional promoter and 3′ genomic terminal sequences was amplified by PCR using the pTV as a template and primers 1 and 2 (Fig. 7) . The small PCR product was used as a megaprimer, pairing with primer 3 to amplify the fragment A.
The cDNA clones of VSV NJ encoding M(M48R) and M (M48R + M51R), pTV-VSV NJ (M;M48R) and pTV-VSV NJ (M; M48R + M51R), were generated by replacing the M(wt) gene with the M gene containing the respective mutations. The M gene cDNAs containing the mutations were amplified using primers 8 and 9 (Fig. 7) and pBKS-M NJ (M48R) and pBKS-M NJ (M48R + M51R) as templates. The full-length cDNA clone was digested partially with PacI first and then completely digested with NotI. The PCR products were cut with the same restriction enzymes and cloned into the full-length cDNA clone. The nucleotide changes were confirmed by DNA sequencing.
Generation of inducible cell lines expressing wild type or mutant VSV NJ M proteins
The human embryonic kidney 293 cells expressing M(wt) or M proteins with M to R mutations were generated by using the Flp-In T-Rex Core Kit (Invitrogen) according to the manufacturer's manual. Briefly, the Flp-In T-Rex 293 cell line (Invitrogen) expressing the Tet repressor and containing the Flp recombinase target sequence in its genome was used as a parental cell line. The 293 parental cell line was cotransfected with the pcDNA5-M NJ (wt), pcDNA5-M NJ (M33R), pcDNA5-M NJ (M48R), pcDNA5-M NJ (M51R) or pcDNA5-M NJ (M48R + M51R) and pOG44 encoding Flp recombinase. Several cell colonies which were formed in the presence of the selective agents blasticidine (15 μg/ml) and hygromycin B (400 μg/ml) were isolated, expanded and checked for the expression of M proteins in the presence of tetracycline (1 μg/ml).
Recovery of DI particles and recombinant VSV NJ from cDNA VSV NJ DI particle NJ DI (227-188) was recovered from cDNA by cotransfecting pBKS-N NJ , pBKS-P NJ , pBKS-M NJ (wt) or pBKS-M NJ (M-R mutants), pBKS-G NJ , pBKS-L NJ and pTV-NJ DI (227-188) as described previously (Kim and Kang, 2005) . Recombinant VSV NJ expressing wild type or mutant M protein was recovered from the plasmid DNA by the reverse genetics method employing the BHK cell line expressing bacteriophage T7 RNA polymerase BSR T7/5 (Harty et al., 2001) . BSR T7/5 cells were seeded in a 100 mm culture dish to be approximately 90% confluent in 24 h. The cells were maintained in DMEM supplemented with 5% FBS without antibiotics. The transfection was carried out with Lipofectamine™ 2000 (Invitrogen) according to the manufacturer's protocol. Briefly, the BSR T7/5 cells were contransfected with 10 μg of pBKS-IRES/N NJ , 10 μg of pBKS-IRES/P NJ , 5 μg of pBKS-IRES/L NJ and 15 μg (1.6 pmol) of one of the following plasmids: pTV-VSV NJ (rwt), pTV-VSV NJ (M;M48R) or pTV-VSV NJ (M;M48R + M51R). The culture media was harvested when more than 50% of cells showed cytopathic effects, approximately 48 h after transfection.
Apoptosis assay
Inducible cell lines expressing M(wt), M(M48R), M(M51R) and M(M48R + M51R) of VSV NJ were grown in 60-mm dish until 95% confluency, at which time they were treated with 1 μg/ml of tetracycline for 24 h to induce the expression of M proteins. Cell lysates were prepared to isolate low molecular weight DNA for the DNA fragmentation assay and to measure the caspase-3 activity in the cell lysate. For the DNA fragmentation assay, cells were lysed in 300 μl of TE/Triton buffer [0.2% (v/v) Triton X-100, 10 mM Tris pH 8.0 and 1 mM EDTA]. The cell lysates were treated with RNase A (1.5 μl of 10 mg/ml solution) for 1 h at 37°C. Sodium dodecyl sulfate (12.5 μl of 10% solution) and proteinase K (2 μl of 20 μg/ml solution) were added to the cell lysates and were incubated for 1 h at 50°C. The low molecular weight DNA was extracted by treating the lysate with the same volume of phenol/chloroform/ isoamylalcohol and concentrated by precipitating the DNA with 0.1 volume of 3 M sodium acetate and 2.5 volume of 100% ethanol. The DNA pellet was dissolved in dH 2 O. The DNA was resolved on a 1.5% agarose gel containing ethidium bromide. Caspase-3 activities from the cell lysates were measured using the BD ApoAlert™ Caspase Colorimetric Assay kit (BD Biosciences Clontech) according to the manufacturer's protocol. Briefly, the cells were lysed in 100 μl lysis buffer, protein concentration of the cell lysates was determined by the Bradford method using the Bio-Rad Protein Assay kit (Bio-Rad) and 500 μg of each sample was measured for the caspase-3 activity. All assays were done in triplicate.
Determination of protein expression
Expression of matrix proteins in inducible cell lines was determined by both Western blot analysis and immunoprecipitation analysis. Western blot analysis was carried out using 10 μg of cell lysate and ECL Plus Western Blotting Detection reagents (Amersham Biosciences). The level of GAPDH in the 35 S-met labeled cell lysate was determined by Western blot analysis using a purified goat polyclonal antibody raised against a internal peptide of human GAPDH (Santa Cruz Biotechnology, Inc.). Determination of total cellular protein synthesis after viral infection, immunoprecipitation of M proteins, VSV NJ proteins and human heat shock protein 70 (HSP70) was carried out after labeling the cells with 30 μCi/ml of 35 S-met (1175 Ci/ mmol, PerkinElmer). VSV NJ proteins were immunoprecipitated with rabbit polyclonal antisera against VSV NJ total proteins and the L protein (Kim et al., 2002; Kim and Kang, 2005) . HSP70 was immunoprecipitated with a mouse monoclonal antibody against HSP70 (Santa Cruz Biotechnology, Inc.).
Northern blot analysis
Northern blot analysis of DI particle genomic RNAs in the infected cells was performed as described previously (Kim et al., 2002) .
